Adrenal Flashcards

1
Q

Cortisol metabolic functions

A

provide glucose for the brain
provide substrates for gluconeogenesis
increases: gluconeogenesis, lipolysis, protein catabolism, serum glucose, glycogen synthesis
decreasesL peripheral glucose utilization, protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cortisol BP functions

A

generally increases BP
Increases: Angiotensinogen synthesis, vasucular reactivity to v/cers, epinephrine synthesis, sodium out of cells
decreases: kinins, prostaglandins

At high concentrations, may bind MC receptors in kidneys

ALso increases GFR, decreases water absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cortisol immune function

A

Immunosuppression
leukocytosis via decrease diapedesis of PMNs, increase release from bm
suppresses inflammatory response - stabilizing lysosomes, inhibiting leukocyte igration and phagocytosis
-inhibits proinflammatory actions of ILs and interferons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cortisol miscellaneous action

A

bone: inhibit bone formation, increase bone resorption
growth: inhibit growth
gonads: inhibit response of pituitary to GnRH – decreased gonadotropins and gonadal steroids
CNS: initially causes euphoria, eventually causes irritability, depression, decreased libido
thyroid: may inhibit TSH secretion from pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aldosterone functions

A

Increases ECF
Increases Na resorption and K excretion at DCT
water follows Na

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adrenal androgen functions

A

DHEA, androstenedione, DHEA
functions not well defined, peripherally converted to testosterone, DHT, estradiol
Constitutes 50% circulating testosterone in women, 5% in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of steroid hormones in cells

A

CLASS1 nuclear receptors: steroid receptor family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of hypoadrenalism

A

primary: Addison’s
secondary: low CRH, ATH, pituitary
Exogenous - long term GCs –> adrenal atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Key treatment of adrenal insufficiency

A

If vomiting –> absolutely must have fluid iv administration

should always increase medications if ill/surgery/stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dx of adrena linsufficiency

A

1) patient with postural hypotension, hyponatremia, hyperkalemia +/- pigmentation
2) measure ACTH and baseline control, then do a rapid ACTH stimulation test –> measure cortisol
3) Low ACTH + blunted cortisol response to ACTH –> exogenous GC or secondary adrenal insufficiency
4) insulin induced hypoglycemia test
5) increased ACTH –> atrophy
no change in ACTH –> secondary pituitary/hypothalamic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Addison’s pathophysiology

A

AI adrenalitis - most common cause, associated with other AI disorders (40%)
Granulomatous disease (TB, histoplasmosis, coccidiodes)
Neoplasm: malignant mets, lymphoma, space-occupying in the gland
Hemochromatosis
Amyloidosis
Adrenalectomy
Adrenal hemorrhage
AIDS
Drugs (metyrapone, mitotane, ketoconazole)
Adrenoleukodystrophy
Congenital adrenal hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical features of Addison’s

A
Non-specific until 90% gland destroyed
Muscle weakness/fatigue
weight loss/anoexia
orthostatic Hypotension
Hyponatremia and hyperkalemia due to hypoaldosteronism
Hypoglycemia
Hyperpigmentation (increase in ACTH --> increase in alpha-MSH)
GI disturbances
Amenorrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Addisonian crisis

A

acute deficiency of aldosterone and cortisol, caused by partial adrenal insufficiency
may be expressed folowing severe illness oro ther stress - patient has insufficient adrenal reserve
symptoms: fever, dehydration, nausea, vomiting, hypotension, shock, abdominal pain, coma, and death
- aldosterone/cortisol deficiency –> circulatory collapse
- hyperkalemia –> cardiac arrhythmia or arrest
- low BP –> pre-renal acute renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adrenal leukodystrophy pathogenesis

A

Cause of Addison’s in up to 40% of patients
X-linked deficiency of peroxisomal enzyme involved in catabolism of very long chain fatty acids
- cholesterol esters of VLCFAs accumulate in adrneal, testes, CNS white matter, and peripheral nervous system
- males with ALD may present with severe neurological and/or adrenal problems
Early or late onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ALD symptoms

A

Neurological: emotional liability, learning disorders, seizures, demyelination, death
adrenal symptoms
neurological + adrenal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dx of ALD

A

high concentration of VLCFAs in plasma or blood cells in male with adrenal and CNS problems
MRI - characteristic white matter changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2ndary adrenal insufficiency pathogenesis

A

secondary to long-term GC therapy (most common)

less commonly due to hypothalamic/pituitary dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2ndary adrenal insufficiency symptoms

A

No hyperpigmentation (decreased ACTH)
Mineralocorticoid function normal: RAAS does not rely on ACTH –> no volume depletion/hyperkalemia
Decreased cortisol, increased water –> delusional hyponatremia
Main problems: weakness, fatigue, anorexia, nausea, hypoglycemia, arthalgias/myalgias
secondary may be associated with other features of hypo-/hyperpituitarism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Assessment of patients on long-term steroids

A

leads to atrophy of the adrenal axis
may take up to 2 years after withdrawal to recover normal response in some cases, depending on dose, duration and individual
Rapid ACTH stimulation test may be useful to assess recovery
or simply skip a dose of GC -> assess morning cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cushing’s syndrome pathogenesis

A

Exogenous GCs (most common)
small ACTH producing pituitary adenoma/hyperplasia - most common endogenous case
Ectopic ACTH by non-adrenal neoplasm
- tumours secrete ACTH-like substance
- adults usually due to SCC of lung cancer/ carcinoid
- grossly enlarged adrenal glands with tan brown, diffusely hyperplastic cortex
Bilateral adrenal hyperplasia, adrenal adenoma or adrenal carcinoma
- 25% of endogenous cases
- 80% women
- high cortisol but low ACTH
- opposite adrenal gland is atrophic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cushing’s syndrome symptoms

A
sudden weight gain
central obesit
hypertension
facial plethora
proximal muscle weakness
glucose intolerance/diabetes mellitus
decreased libido, impotence
depression/psychosis
osteopenia/osteoporosis
easy bruising
hyperlipidemia
menstrual disorders
Violaceous striae, wider than 1 cm
recurrent opportunistic or bacterial infections
acne
hirsutism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cushing’s tests

A

dexamethasone suppression test and ACTH, urine catecholamines and metanephrines, aldo:renin ratio
if any positive –> surgery
6-12% secrete cortisol (subclinical CUshing’s), 2-3% are pheochromocytomas, smaller percent secretes aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dexamethasone suppression test

A

exogenous steroid, provides negative feedback to the pituitary to suppress the secretion of ACTH
unable to pass BBB
Binds to GC receptors in the pituitary gland (outside the BBB)

Low dose: should suppress cortisol without pathology
High dose: exerts negative control on the pituitary ACTH producing cells, but not on ectopic ACTH producing cells or adrenal adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Conn’s syndrome pathogenesis

A

primary hyperaldosteronism due to adrneal pathology
Now thought to be common - up to 10% of hypertensives
Adrenal adenoma secreting aldosternoe (APA): approx 30%
Idiopathic hyperaldosteronism (IHA) :approx 70%
other rare causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Conn’s syndrome clinical features

A

main feature: elevated aldosterone + suppressed plasma renin/plasma renin activity in pateint with HTN and hypokalemia
HTN secondary to sodium and water retention
sodium concentration usually normal (water follows)
Volume expansion –> stretch myocytes of heart –> ANP –> increased Na retention by RAAS inhibition
Spontaneous hypokalemia in most
- muscle weakness, abnormal glucose tolerance, nephrogenic diabetes insipidus, ECG changes
- sodium administration may provoke hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Conn’s syndrome diagnosis

A

Patient with hypertension with unexplained hypokalemia, resistant hypertension or adrenal incidentaloma

1) Increased aldosterone:renin ratio
2) confirmatory saline infusion (suppression test)
3) failure to suppress aldosterone –> primary aldosteronism, test to differentiate APA from IHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Conn’s syndrome treatment

A

APA: surgery
IHA: medical - spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Conn’s syndrome radiologic diagnosis

A

CT
bilateral adrenal venous sampling - most definitive
if different between sides –> adenoma
same - IHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Secondary hyperaldosteronism causes

A
decreased renal perfusion
renal artery stenosis
volume depletion
Renin-secreting tumour
aortic coarctation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Congenital adrenal hyperplasia causes

A

hereditary deficiency of enzymes in steroid biosynthetic pathway
Most common: 21-hydroxylase deficiency (95%) - newborn screening in BC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

21-hydroxylase def physical findings

A

severe:

  • decreased aldosterone and cortisol
  • Addisonian crisis at early age
  • excess androgen causes virilization in enwborn females and precocious puberty in males

Less severe:

  • cortisol/aldosterone output compensated
  • main problem: excess androgens - may only become apparently after puberty
  • complications include: virilization, primary amenorrhea, rapid growth initially with premature epiphyseal closure, acne, precocious puberty, development of early sex drive, hirsutism

Non-classic: >1/100, carriers 1/7
- may be a common cause of hirsutism in females in some populatiosn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

21-hydroxylase def diagnosis

A

presentation (severe): child with adrenal insufficiency (hypotension, electrolyte abnormalities) and females with signs of virilization (ambiguous genitalia)
Definitive test: 17 hydroxyprogesterone (built up metabolite)
Other abnormalities: low cortisol, increased androgens, including testosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

21-hydroxylase deficiency treatment

A

Glucocorticoid +/- mineralocorticoid

Flutamide to block androgen effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

11-hydroxylase def pathogenesis

A

cortisol level may/may not be adequate
excess androgen production problematic
Increased level of 11-hydroxycorticosterone –> MC activity –> hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

11-hydroxylase def diagnosis

A

increased 11-deoxycortisol

36
Q

11-hydroxylase deficiency tx

A

GCs

patients are not hypotensive, not at risk for Addisonian crisis

37
Q

Adrenal incidentaloma pathogenesis

A

abdominal CT - 2% of population
80% non-functional
masses may be due to adenoma, carcinoma, pheochromocytoma, cyst, myelipoma, metastases
small lesions ( followup CT in 6 months
Large tumours/symptomatic –> biochemical investigation

38
Q

Non-malignant adrenal incidentalomas

A

Hemorrhage
Cyst
Abscess
Chronic granulomatous disease (TB, histoplasmosis)

39
Q

Adrenal incidentalomas - benign neoplasms

A
myelolipoma
ganglioneuroma
adrenocortical adneoma
hemangioma
pheochromocytoma
leiomyoma
40
Q

Adrenal incidentalomas - malignant neoplasms

A

neuroblastoma (most commonly: extracranial neural tumour in kids)
Adrenocortical adenoma (most commonly found incidentaloma)
pheochromocytoma (10% disease - 10% extra adrenal, 10% metastasize, 10% bilateral)

41
Q

Adrenal incidentalomas - bilateral masses

A
pituitary adenoma (Cushing's)
adrenal nodular hyperplasia
ectopic ACTH/CRH production
metastases
pheochromocytoma
lymphoma
hemorrhage
42
Q

Adrenal cortical adenoma

A

2/3 women, detected at 30-40 years
benign appearance, Conn’s
- zona fasciculata –> Cushing’s
- Zona reticularis –> adrenogenital syndrome
If non-functional, adjacent adrenal has normal cortical thickness
If functional then adjacent adrenal will be atrophic

43
Q

Neuroblastoma

A

Most common extra-cranial solid tumour in infancy
- most common before 8 yo
- 80% before 4
- responsible for 15% of childhood cancer deaths
- early metastases: bone marrow, bone , lymph, meninges, liver, ovary, paratesticular
SNS malignancy from neuroblasts
Pattern of distribution follows sites of primary disease
- 25% adrenal medulla
- sympathetic chain
Many chromosomal and molecular abnormalities identified
- MYCN-verexpressed oncogene (25% cases, poor prognosis)
- H-RAS: lower disease state

44
Q

Schmida histopathologic classification

A
degree of neuroblast differnetiation
presence/absence of schwannianor stromal development (stromal-rich, stromal-poor)
index of cellular proliferation
nodular pattern
age
45
Q

Metastasis to adrenal

A

common at autopsy
usually bilateral
most common primary tumours are breast/lung
usually does not affect adrenal function unless extensive (>80%)
gross pathology: single or multiple firm masses replacing some/all adrenal gland
- larger mets –> hemorrhage, necrosis

46
Q

Natural catecholamines

A

NE
E
dopamine

47
Q

Norepinephrine souces, fxn, adrenergic receptors

A

SNS-major
adrenal medulla
CNS

fxn: neurotransmitter, vasoactive
alpha 1, 2 and beta 1

48
Q

Epinephrine sources, fxn, adrenergic receptors

A

Adrenal medulla - major
SNS, CNS

Metabolic (carb metabolism), vasoactive

beta2

49
Q

Dopamine sources, fxn, adrenergic receptors

A

CNS (hypothalamus)
inhibit prolactin
dopamine receptors

50
Q

alpha stimulation effects

A
v/c
insulin secretino
sweating
piloerection
glycogenolysis
51
Q

beta stimulation effects

A
vasodilation
insulin release
cardiac contraction rate increases (1)
relaxation of smooth muscle in GI
brochondilation (2)
stimulation of renin release
lipolysis
52
Q

Catecholamine formation pathway

A

Phenylalanine/diet –> tyrosine –> tyrosine hydroxylase RDS –> DOPA –> dopamine granules in CNS –> dopamine beta hydroxylase –> NE (SNS) –> PNMT (induced by cortisol) –> Epi

53
Q

Stimulation of catecholamine release

A
hypotension
hypoxia
cold
MI
angina
hemorrhage
surgery
pain
emotion
anoxia (NE)
hypoglycemia(E)
54
Q

Catecholamine metabolism

A

once relapsed, rapidly degraded by COMT & MAO, only 2% excreted as free CA
MAO COMT –> VMA, metanpehrine/normetanephrine
2% as unaltered CA, 20% metanephrine, rest as VMA

55
Q

Pathogenesis pheochromocytoma

A

rare, usually benign tumour of the adrenal medulla and SNS
90% in adrenal, 10% malignant, 10% bilateral
Curable
can cause serious hypertensive crisis
Familial: MEN 2A, MEN2B, neurofibromatosis, von Hippel Lindau disease
Paragangliomas: neuroendocrime tumours, 1-3% can secrete catecholamines, associated with succinate dehydrogenase mutations

56
Q

Pheochromocytoma clinical features

A
Key: persistent orepisodic hypertension
sweating
headache
palpitations
tachycardia
anxiety/fear of impedingdeath
Others:
weight loss
nausea and vomiting
cold hands and feet
chest pain
visual disturbances
57
Q

Pheochromocytoma symptom triggers

A

compression of tumour
change in position
exercise
emotional distress

58
Q

Pheochromocytoma investigations

A

24 hour urine metanephrins (met and normet), catecholamines (epi and norepi) and VMA
Radiology: CT and MRI
Nuclear medicine: I-131/I-123 MIBG (taken up by tissues that make catecholamines)
Tumour marker: chromogranin A

59
Q

MEN1 pathology

A

3P triad: parathyroid (90%), pancreatic islet cell (75% - insulin/gastrin), anterior pituitary (25% - most prolactin, but may be others/nonfunctional)
Most rarely associated with carcinoid, adrenal cortical and lipoid tumours
200 / million
Auosomal dominant with high penetrance, genetic cause linked to nuclear protein MENIN

60
Q

MEN1 clinical presentation

A

dependent on hormone being secreted

clinically evident 40 yo

61
Q

MEN1 testing

A
Biochemical abnormality detetable <20
DNA mnutation
Annual screening for high risk patients
Biochemical tests:
- fasting glucose and insulin
- calcium and PTH
- Gastrinn
- Prolactin, IGF1
62
Q

MEN2A pathology

A

90% of MEN2
Triad: medullary carcinoma of thyroid (MCT)
pheochromocytoma
hyperparathyroidism

63
Q

MEN2 clinical presentation

A

mass in neck
less commonly: present with hyperparathyroidism/pheochromocytoma

2B recognized earlier because of facial appearance and ganglioneuromas causing GI problems

64
Q

MEN2B pathology

A

MCT and pheochromocytoma common
hyperparathyroid rare
Penetrance high, presentation earlier than 2A
Developmental abnormalities: ganglioneuromas, neuromas of lips/tongue, marfinoid features, skeletal anomalies

65
Q

MEN2 investigations

A

Dx: fine needle biopsy, elevated calcitonin
Screening: early DNA testing for all 1st degree relatives
MCT can be lethal befoer age 6, some advocate prophylactic thyroidectomy early in life

RET Proto-oncogene (receptor TK in neural crest cells) responsible for MEN2
activating mutation of tyrosine kinase

66
Q

Use of natural/synthetic adrenal steroids

A

Treatment of endocrine disorders - replacement therapy

Treatment of endocrine disorders

67
Q

Use of steroids in endocrine disorders

A

Chronic adrenal insufficiency - mimic endogenous rhythm, increase dose during stress
Acute adrenal insufficiency, bolus
Congenital adrenal hyperplasia

68
Q

Use of steroids in non-endocrine disorders

A
RA, SLE, temporal arteritis, polymyalgia rheumatica, poly/dermatomyositis, etc
Anaphylaxis: epinephrine
Bronchial asthma
IBD
Minimal change glomerulonephritis
Dermatologic
Cerebral edema, increased intracranial pressure, spinal cord injury, MS
Ophthalmologic
organ transplantation
Lymphoma, ALL
Prenatal lung maturation 
Postoperative nausea/vomiting prophylaxis
69
Q

Inhibitors of glucocorticoid synthesis

A

P450 inhibitors: aminoglutethimide, metyrapone, ketoconazole, etomidate
5-alpha reductase inhibitors: finasteride

70
Q

Inhibitors of GC action

A

Mifepristone (“anti-progesterone”)
Progesterone receptor blocker, used for termination of early pregnanices
Acts as a glucocorticoid receptor blocker at high doses

71
Q

Cell types in adrenal medulla

A

Neural crest cells
Chromaffin
Sustentacular
Ganglion

72
Q

Chromaffin cells

A
small nests and cords of cells
large polygonal, poorly-defined borders
granular basophilic cytoplasma
variation in cell size
secretes catecholamines
73
Q

Sustentacular cells

A

supporting spindle cells at the pierphery of nests of chromafifin cells, rich vasculature

74
Q

Ganglion cells

A

occasional single cell associated with myelinated nerve bundles

75
Q

GC acting as MC

A

Kidney has enzyme which converts cortisol to cortisone (inactive)
But if high level of cortisol –> overwhelm enzyme, acts as a MC (aldosterone)

76
Q

2-day high dose dexamethasone test

A

used in differential diagnosis of Cushing syndrome (pituitary vs ectopic) but not that useful
30-40% of ectopic sources still suppressed

77
Q

BIPSS

A

most definitive means of accurately distinguishing pituitary from non-pituitary ACTH-dependent CUshing syndrome
but MUST establish diagnosis for Cushing first - gradient still seen in normal patients!

78
Q

Cushing’s disease treatment

A

surgery of pituitary lesion

pharmacological inhibition of ACTH secretion

79
Q

Ectopic ACTH treatment

A

surgical possible if tumour benign, but metastatic difficult

steroid synthesis blockers (metyrapone, ketoconazole)

80
Q

Adrenal tumour treatment

A

Unilateral adrenalectomy is excellent

Supplement with GC until axis back to normal

81
Q

Urine free cortisol

A

50% sens 100% spec

82
Q

Midnight serum cortisol

A

more specific than urine

83
Q

Midnight salivary cortisol

A

Now recommended - highest sensitivity and specificity

may still have false positives due to abnormal sleep/wake cycles and stress

84
Q

RET proto oncogene

A

activating mutations –> MEN 2A MEN 2B familial MCT

inactivating - associated with Hirschsprung’s disease

85
Q

Cortisol in serum

A

bound to CBG or albumin

86
Q

Cortisol secretion per day

A

10 mg / day

can go up to 100x during stress

87
Q

Cortisol PK

A

effect prolonged even after elimination (half life not useful)